研究者詳細 - 安藤　雄一

論文 - 安藤　雄一

分割表示 124 件中 81 - 100 件目／全件表示 >>

Recent progress of chemotherapy and biomarkers for gastroesophageal cancer

Maeda, O; Ando, Y

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY 11 巻 ( 7 ) 頁： 518 - 526 2019年7月

Alterations in gene expression and DNA methylation profiles in gastric cancer cells obtained from ascitic fluids collected before and after chemotherapy.

Maeda O, Matsuoka A, Furukawa K, Miyahara R, Hirooka Y, Ando Y

Molecular and clinical oncology 11 巻 ( 1 ) 頁： 91 - 98 2019年7月

Low-dose chemotherapy with methotrexate and vinblastine for patients with refractory desmoid tumors: A second report of relationship between efficacy and various factors.

Nishida, Y; Sakai, T; Shimizu, K; Urakawa, H; Arai, E; Ikuta, K; Ando, Y; Ishiguro, N

JOURNAL OF CLINICAL ONCOLOGY 37 巻 ( 15 ) 2019年5月

Influence of tumor size and Eastern Cooperative Oncology Group performance status (ECOG PS) at baseline on patient (pt) outcomes in lenvatinib-treated radioiodine-refractory differentiated thyroid cancer (RR-DTC).

Wirth, LJ; Leboulleux, S; Kiyota, N; Tahara, M; Muro, K; Ahn, MJ; Ando, Y; Taylor, MH; Takahashi, S; Kim, SB; Misir, S; Dutcus, CE; Xie, R; Joshi, PR; Hughes, BGM; Aller, J; Krzyzanowska, MK; Capdevila, J

JOURNAL OF CLINICAL ONCOLOGY 37 巻 ( 15 ) 2019年5月

Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II study

Takano, N; Yamada, S; Hirakawa, A; Yokoyama, Y; Kawashima, H; Maeda, O; Okada, T; Ohno, E; Yamaguchi, J; Ishikawa, T; Sonohara, F; Suenaga, M; Takami, H; Hayashi, M; Niwa, Y; Hirooka, Y; Ito, Y; Naganawa, S; Ando, Y; Nagino, M; Goto, H; Fuji, T; Kodera, Y

NAGOYA JOURNAL OF MEDICAL SCIENCE 81 巻 ( 2 ) 頁： 233 - 239 2019年5月

Phase I study of alpelisib (BYL719), an α-specific PI3K inhibitor, in Japanese patients with advanced solid tumors

Ando, Y; Iwasa, S; Takahashi, S; Saka, H; Kakizume, T; Natsume, K; Suenaga, N; Quadt, C; Yamada, Y

CANCER SCIENCE 110 巻 ( 3 ) 頁： 1021 - 1031 2019年3月

Modified Docetaxel plus Cisplatin plus Capecitabine (DCX) for Gastric Cancer

Maeda, O; Ando, Y; Matsuoka, A; Furukawa, K; Funasaka, K; Miyahara, R; Hirooka, Y; Goto, H

DIGESTION 99 巻 ( 1 ) 頁： 113 - 113 2019年

Spiritual pain and care needs of elderly cancer patients facing palliative chemotherapy decision-making: Qualitative study.

Tsuboi, R; Sugishita, M; Hirakawa, H; Ando, Y

JOURNAL OF CLINICAL ONCOLOGY 36 巻 ( 34 ) 2018年12月

Phase 1 study of olaratumab plus doxorubicin in Japanese patients with advanced soft-tissue sarcoma

Yonemori, K; Kodaira, M; Satoh, T; Kudo, T; Takahashi, S; Nakano, K; Ando, Y; Shimokata, T; Mori, J; Inoue, K; Oakley, GJ; Sakaguchi, S; Tamura, K

CANCER SCIENCE 109 巻 ( 12 ) 頁： 3962 - 3970 2018年12月

Reporting harms more transparently in trials of cancer drugs

Gyawali, B; Shimokata, T; Honda, K; Ando, Y

BMJ-BRITISH MEDICAL JOURNAL 363 巻頁： k4383 2018年11月

Cabozantinib in Hepatocellular Carcinoma

Maeda Osamu, Ando Yuichi

NEW ENGLAND JOURNAL OF MEDICINE 379 巻 ( 14 ) 頁： 1384 - 1384 2018年10月

Cabozantinib in Hepatocellular Carcinoma.

Maeda O, Ando Y

The New England journal of medicine 379 巻 ( 14 ) 頁： 1384 2018年10月

A longitudinal study of a new point-of-care nerve conduction device for quantitative assessment of chemotherapy-induced peripheral neurotoxicity

Matsuoka, A; Maeda, O; Mitsuma, A; Uehara, K; Nakayama, G; Nagino, M; Kodera, Y; Ando, Y

ANNALS OF ONCOLOGY 29 巻 2018年10月

Docetaxel, cisplatin and fluorouracil as neoadjuvant chemotherapy for esophageal cancer with prophylactic pegfilgrastim

Maeda, O; Koike, M; Fukaya, M; Miyata, K; Iwata, N; Nagino, M; Kodera, Y; Ando, Y

ANNALS OF ONCOLOGY 29 巻 2018年10月

Outpatient chemotherapy for patients with unresectable or metastatic bone sarcomas

Urakawa, H; Nishida, Y; Mitsuma, A; Maeda, O; Sugishita, M; Shimokata, T; Mizutani, T; Arai, E; Ikuta, K; Hamada, S; Ota, T; Ishiguro, N; Ando, Y

ANNALS OF ONCOLOGY 29 巻 2018年10月

Phase I study of spartalizumab (PDR001), an anti-PD1 mAb, in Japanese patients with advanced malignancies

Ando, Y; Doi, T; Mitsuma, A; Mizutani, T; Toyoda, M; Imamura, Y; Kiyota, N; Naito, Y; Matsubara, N; Ishihara, K; Tajima, T; Tokushige, K; Cameron, S; Minami, H

ANNALS OF ONCOLOGY 29 巻 2018年10月

Randomized Phase II Trial of CapOX plus Bevacizumab and CapIRI plus Bevacizumab as First-Line Treatment for Japanese Patients with Metastatic Colorectal Cancer (CCOG-1201 Study)

Nakayama, G; Mitsuma, A; Sunagawa, Y; Ishigure, K; Yokoyama, H; Matsui, T; Nakayama, H; Nakata, K; Ishiyama, A; Asada, T; Umeda, S; Ezaka, K; Hattori, N; Takami, H; Kobayashi, D; Tanaka, C; Kanda, M; Yamada, S; Koike, M; Fujiwara, M; Fujii, T; Murotani, K; Ando, Y; Kodera, Y

ONCOLOGIST 23 巻 ( 8 ) 頁： 919 - 927 2018年8月

Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer

Yamada, S; Fujii, T; Yokoyama, Y; Kawashima, H; Maeda, O; Suzuki, K; Okada, T; Ono, E; Yamaguchi, J; Takano, N; Takami, H; Hayashi, M; Niwa, Y; Hirooka, Y; Ito, Y; Naganawa, S; Ando, Y; Nagino, M; Goto, H; Kodera, Y

CANCER CHEMOTHERAPY AND PHARMACOLOGY 81 巻 ( 5 ) 頁： 815 - 821 2018年5月

Patients With Antithyroid Antibodies Are Prone To Develop Destructive Thyroiditis by Nivolumab: A Prospective Study.

Kobayashi T, Iwama S, Yasuda Y, Okada N, Tsunekawa T, Onoue T, Takagi H, Hagiwara D, Ito Y, Morishita Y, Goto M, Suga H, Banno R, Yokota K, Hase T, Morise M, Hashimoto N, Ando M, Kiyoi H, Gotoh M, Ando Y, Akiyama M, Hasegawa Y, Arima H

Journal of the Endocrine Society 2 巻 ( 3 ) 頁： 241 - 251 2018年3月

Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial 査読有り

Tsukuura, H; Miyazaki, M; Morita, T; Sugishita, M; Kato, H; Murasaki, Y; Gyawali, B; Kubo, Y; Ando, M; Kondo, M; Yamada, K; Hasegawa, Y; Ando, Y

ONCOLOGIST 23 巻 ( 3 ) 頁： 367 - 374 2018年3月

　前のページ - 次のページ　

<安藤 雄一>

論文 - 安藤 雄一

<安藤　雄一>

論文 - 安藤　雄一